scPharmaceuticals Inc.

CIK 1604950 · operating company. SEC filings, financial statements, 10-K sections, 8-K items and insider trades for scPharmaceuticals Inc..

Recent SEC filings

FiledFormAccession number
Feb 11, 2026SCHEDULE 13G/A0001357550-26-000003
Nov 19, 2025EFFECT9999999995-25-003318
Nov 19, 2025EFFECT9999999995-25-003314
Nov 19, 2025EFFECT9999999995-25-003315
Nov 14, 2025SCHEDULE 13G/A0000935836-25-000685
Oct 17, 202515-12G0001193125-25-242425
Oct 14, 2025SCHEDULE 13G0000902664-25-004400
Oct 8, 2025SCHEDULE 13G/A0001193125-25-234639
Oct 7, 2025S-8 POS0001193125-25-233485
Oct 7, 2025POS AM0001193125-25-233428
Oct 7, 2025S-8 POS0001193125-25-233508
Oct 7, 2025S-8 POS0001193125-25-233488
Oct 7, 202525-NSE0001354457-25-000996
Oct 7, 2025S-8 POS0001193125-25-233479
Oct 7, 202540001193125-25-233539
Oct 7, 202540001193125-25-233530
Oct 7, 202540001193125-25-233528
Oct 7, 202540001193125-25-233537
Oct 7, 202540001193125-25-233532
Oct 7, 2025S-8 POS0001193125-25-233461
Oct 7, 2025S-8 POS0001193125-25-233469
Oct 7, 2025POS AM0001193125-25-233434
Oct 7, 20258-K0001193125-25-232754
Oct 7, 2025SC TO-T/A0001193125-25-232632
Oct 7, 2025S-8 POS0001193125-25-233497